Magnesium and tumors: Ally or foe?

Cancer Treatment Reviews

Volumn 35, Issue 4, 2009, Pages 378-382

  Wolf, Federica I ^a   Cittadini, Achille R M ^a   Maier, Jeanette A M ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Angiogenesis; Cetuximab; Cisplatin; Endothelial cells; Hypomagnesaemia; Inflammation; Metastasis; Tumor growth

Indexed keywords

ANTHRACYCLINE DERIVATIVE; C REACTIVE PROTEIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; IRINOTECAN; MAGNESIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; VASCULOTROPIN;

ADD ON THERAPY; CANCER INVASION; CARCINOGENESIS; COLORECTAL CANCER; DRUG MEGADOSE; ELECTROLYTE DISTURBANCE; HUMAN; HYPOMAGNESEMIA; INFLAMMATION; KIDNEY TUBULE ABSORPTION; MAGNESIUM BLOOD LEVEL; METASTASIS; NEOPLASM; NEPHROTOXICITY; NONHUMAN; REVIEW; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL PROLIFERATION; CISPLATIN; FEMALE; HUMANS; MAGNESIUM; MALE; NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 67049149836     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2009.01.003     Document Type: Review

References (51)

1. Rubin H. The logic of the membrane, magnesium, mitosis (MMM) model for the regulation of animal cell proliferation. Arch Biochem Biophys 458 (2007) 16-23
2. Wolf F.I., Fasanella S., Tedesco B., Torsello A., Sgambato A., Faraglia B., et al. Regulation of magnesium content during proliferation of mammary epithelial cells (HC-11). Front Biosci 9 (2004) 2056-2062
3. Wolf F.I. TRPM7: channeling the future of cellular magnesium homeostasis?. Sci STKE 233 (2004) 23
4. Wolf F.I., Maier J.A., Nasulewicz A., Feillet-Coudray C., Mazur A., Simonacci M., et al. Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment. Arch Biochem Biophys 458 1 (2007) 24-32
5. Sartori S., Nielsen I., Tassinari D., Mazzotta D., Vecchiatti G., Sero A., et al. Serum and erythrocyte magnesium concentrations in solid tumours: relationship with stage of malignancy. Magnes Res 5 3 (1992) 189-192
6. Mune T., Yasuda K., Ishii M., Matsunaga T., and Miura K. Tetany due to hypomagnesemia induced by cisplatin and doxorubicin treatment for synovial sarcoma. Int Med 32 5 (1993) 434-437
7. Evans T.R., Harper C.L., Beveridge I.G., Wastnage R., and Mansi J.L. A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cisplatin chemotherapy with continuous infusion 5-fluorouracil. Eur J Cancer 31A 2 (1995) 174-178
8. Al-Tweigeri T., Magliocco A.M., and DeCoteau J.F. Cortical blindness as a manifestation of hypomagnesemia secondary to cisplatin therapy: case report and review of literature. Gynecol Oncol 72 1 (1999) 120-122
9. Hodgkinson E., Neville-Webbe H.L., and Coleman R.E. Magnesium depletion in patients receiving cisplatin-based chemotherapy. Clin Oncol (R Coll Radiol) 18 9 (2006) 710-718
10. Yao X., Panichpisal K., Kurtzman N., and Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci 334 2 (2007) 115-124
11. Schrag D., Chung K.Y., Flombaum C., and Saltz L. Cetuximab therapy and symptomatic hypomagnesemia. J Natl Cancer Inst 97 16 (2005) 1221-1224
12. Fakih M.G., Wilding G., and Lombardo J. Cetuximab-induced hypomagnesemia in patients with colorectal cancer. Clin Colorectal Cancer 6 2 (2006) 152-156
13. Perrin C., Fabre C., Raoul J.L., and Boucher E. Behavioral disorders secondary to profound hypomagnesemia in a patient given cetuximab for metastatic colorectal cancer hypomagnesemia due to cetuximab treatment. Acta Oncol 45 8 (2006) 1135-1136
14. Tejpar S., Piessevaux H., Claes K., Piront P., Hoenderop J.G., Verslype C., et al. Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study. Lancet Oncol 8 5 (2007) 387-394
15. Dai L.J., Ritchie G., Kerstan D., Kang H.S., Cole D.E., and Quamme G.A. Magnesium transport in the renal distal convoluted tubule. Physiol Rev 81 1 (2001) 51-84
16. Muallem S., and Moe O.W. When EGF is offside, magnesium is wasted. J Clin Invest 117 8 (2007) 2086-2089
17. 2+ absorption. J Biol Chem 279 1 (2004) 19-25
18. Rondón L.J., Groenestege W.M., Rayssiguier Y., and Mazur A. Relationship between low magnesium status and TRPM6 expression in the kidney and large intestine. Am J Physiol Regul Integr Comp Physiol 294 6 (2008) R2001-R2007
19. Schlingmann K.P., Weber S., Peters M., Niemann Nejsum L., Vitzthum H., Klingel K., et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31 2 (2002) 166-170
20. Alexander R.T., Hoenderop J.G., and Bindels R.J. Molecular determinants of magnesium homeostasis: insights from human disease. J Am Soc Nephrol 19 8 (2008) 1451-1458
21. Groenestege W.M., Thébault S., van der Wijst J., van den Berg D., Janssen R., Tejpar S., et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 117 8 (2007) 2260-2267
22. Atsmon J., and Dolev E. Drug-induced hypomagnesaemia: scope and management. Drug Saf 28 9 (2005) 763-788
23. NCI-CTCAE: .
24. Vincenzi B., Santini D., and Tonini G. Biological interaction between anti-epidermal growth factor receptor agent cetuximab and magnesium. Exp Opin Pharmacother 9 8 (2008) 1267-1269
25. Vincenzi B., Santini D., Galluzzo S., Russo A., Fulfaro F., Battistoni Silletta.M., et al. Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome. Clin Cancer Res 14 13 (2008) 4219-4224
26. Sgambato A., Wolf F.I., Faraglia B., and Cittadini A. Magnesium depletion causes growth inhibition, reduced expression of cyclin D1 and increased expression of p27kip1 in normal but not in transformed mammary epithelial cells. J Cell Physiol 180 2 (1999) 245-254
27. Wolf F.I., and Trapani V. Cell (Patho)physiology of Magnesium. Clin Sci 114 1 (2008) 27-35
28. Touyz R.M., and Yao G. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. J Cell Physiol 197 3 (2003) 326-335
29. Wolf F.I., Trapani V., Simonacci M., Boninsegna A., Mazur A., and Maier J.A.M. Magnesium deficiency affects mammary epithelial cell proliferation: involvement of oxidative stress. Nutr Cancer 61 (2009) 1131-1136
30. Blache D., Devaux S., Joubert O., Loreau N., Schneider M., Durand P., et al. Long-term moderate magnesium-deficient diet shows relationships between blood pressure, inflammation and oxidant stress defense in aging rats. Free Radic Biol Med 41 2 (2006) 277-284
31. Guerrero-Romero F., and Rodríguez-Morán M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev 22 6 (2006) 471-476
32. Wolf F.I., Trapani V., and Cittadini A. Magnesium and the control of cell proliferation: looking for a needle in a haystack. Magnes Res 21 2 (2008) 83-91
33. Nasulewicz A., Wietrzyk J., Wolf F.I., Dzimira S., Madej J., Maier J.A., et al. Magnesium deficiency inhibits primary tumor growth but favors metastasis in mice. Biochim Biophys Acta 1739 1 (2004) 26-32
34. Maier J.A.M., Nasulewicz-Goldeman A., Simonacci M., Boninsegna A., Mazur A., and Wolf F.I. Insights into the mechanisms involved in magnesium-dependent inhibition of primary tumor growth. Nutr Cancer 59 2 (2007) 192-198
35. Malpuech-Brugere C., Nowacki W., Daveau M., Gueux E., Linard C., Rock E., et al. Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta 1501 (2000) 91-98
36. Mazur A., Maier J.A.M., Rock E., Gueux E., Nowacki W., and Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 458 1 (2007) 48-56
37. Kerbel R.S. Tumor angiogenesis. New Engl J Med 358 19 (2008) 2039-2049
38. Lapidos K.A., Woodhouse E.C., Kohn E.C., and Masiero L. Mg(++)-induced endothelial cell migration: substratum selectivity and receptor-involvement. Angiogenesis 4 1 (2001) 21-28
39. Bernardini D., Nasulewicz A., Mazur A., and Maier J.A.M. Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis. Front Biosci 10 (2005) 1177-1182
40. Maier J.A.M., Malpuech-Brugere C., Zimowska W., Rayssiguier Y., and Mazur A. Low magnesium promotes endothelial dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 1689 (2004) 13-24
41. Ferré S., Mazur A., and Maier J.A.M. Low-magnesium induces senescent features in cultured human endothelial cells. Magnes Res 20 1 (2007) 66-71
42. Jiri B., Hodny Z., and Jiri L. Cytokine loops driving senescence. Nat Cell Biol 10 (2008) 887-889
43. Nasulewicz A., Zimowska W., Bayle D., Dzimira S., Madej J., Rayssiguier Y., et al. Changes in gene expression in the lungs of Mg-deficient mice are related to an inflammatory process. Magnes Res 17 4 (2004) 259-263
44. Balkwill F., and Coussens L.M. Cancer: an inflammatory link. Nature 431 7007 (2004) 405-406
45. Mantovani A., Allavena P., Sica A., and Balkwill F. Cancer-related inflammation. Nature 454 7203 (2008) 436-444
46. Kobayashi H., Boelte K.C., and Lin P.C. Endothelial cell adhesion molecules and cancer progression. Curr Med Chem 14 4 (2007) 377-386
47. Ma W., Chen J., Xue X., Wang Z., Liu H., Wang T., et al. Alteration in gene expression profile and biological behavior in human lung cancer cell line NL9980 by nm23-H1 gene silencing. Biochem Biophys Res Commun 371 3 (2008) 425-430
48. Boissan M., Wendum D., Arnaud-Dabernat S., Munier A., Debray M., Lascu I., et al. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. J Natl Cancer Inst 97 (2005) 836-845
49. Song Y., Li T.Y., van Dam R.M., Manson J.E., and Hu F.B. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 85 4 (2007) 1068-1074
50. King D.E., Mainous A.G., Geesey M.E., and Woolson R.F. Dietary magnesium and C-reactive protein levels. Am J Clin Nutr 24 (2005) 166-171
51. Rodríguez-Morán M., and Guerrero-Romero F. Serum magnesium and C-reactive protein levels. Arch Dis Child 93 8 (2008) 676-680